本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

22.80
-1.3500-5.59%
成交量:12.83万
成交额:298.00万
市值:14.71亿
市盈率:-6.84
高:24.06
开:24.06
低:22.75
收:24.15
52周最高:40.22
52周最低:20.32
股本:6,452.62万
流通股本:4,561.25万
量比:0.41
换手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):-3.3325
每股收益(LYR):-0.1163
净资产收益率:-61.10%
总资产收益率:-35.87%
市净率:4.26
市盈率(LYR):-196.11

数据加载中...

2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/26

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/18

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]